LJ Goldstein

763 total citations
30 papers, 634 citations indexed

About

LJ Goldstein is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, LJ Goldstein has authored 30 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in LJ Goldstein's work include Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Treatment and Pharmacology (8 papers). LJ Goldstein is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Treatment and Pharmacology (8 papers). LJ Goldstein collaborates with scholars based in United States, United Kingdom and Italy. LJ Goldstein's co-authors include Joan James, Edward D. Lustbader, Caryn Lerman, Colleen Burke Sands, Andrew Balshem, Mary B. Daly, P. Engstrom, Hanan Galski, M M Gottesman and I Aksentijevich and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

LJ Goldstein

28 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LJ Goldstein United States 7 386 248 138 125 96 30 634
P. Engstrom United States 6 336 0.9× 220 0.9× 138 1.0× 139 1.1× 85 0.9× 9 714
Susan Tinley United States 13 240 0.6× 490 2.0× 63 0.5× 125 1.0× 76 0.8× 35 824
Philippe Vennin France 17 310 0.8× 495 2.0× 145 1.1× 231 1.8× 137 1.4× 56 1.1k
Marian B. E. Menke‐Pluijmers Netherlands 22 342 0.9× 341 1.4× 116 0.8× 112 0.9× 70 0.7× 47 1.0k
John Malick United States 11 136 0.4× 333 1.3× 103 0.7× 85 0.7× 105 1.1× 12 627
Nancy Feldman United States 11 174 0.5× 249 1.0× 47 0.3× 114 0.9× 45 0.5× 24 563
Brita Arver Sweden 17 298 0.8× 562 2.3× 127 0.9× 112 0.9× 99 1.0× 30 952
Carolyn Durham United States 10 133 0.3× 679 2.7× 194 1.4× 124 1.0× 174 1.8× 15 867
Jocelyne Chiquette Canada 14 184 0.5× 350 1.4× 62 0.4× 154 1.2× 45 0.5× 39 542
R Davidson United Kingdom 9 120 0.3× 346 1.4× 108 0.8× 159 1.3× 92 1.0× 12 511

Countries citing papers authored by LJ Goldstein

Since Specialization
Citations

This map shows the geographic impact of LJ Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LJ Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LJ Goldstein more than expected).

Fields of papers citing papers by LJ Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LJ Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LJ Goldstein. The network helps show where LJ Goldstein may publish in the future.

Co-authorship network of co-authors of LJ Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of LJ Goldstein. A scholar is included among the top collaborators of LJ Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LJ Goldstein. LJ Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, BP, et al.. (2018). Economic Impact of Laparoscopic Vs Open Low Anterior Resection for Rectal Cancer Surgery: A Budget Impact Analysis. Value in Health. 21. S21–S22. 1 indexed citations
2.
Gatalica, Zoran, et al.. (2017). Abstract P2-05-09: Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer (TNBC). Cancer Research. 77(4_Supplement). P2–5. 1 indexed citations
3.
Xiu, Joanne, Elias Obeid, Zoran Gatalica, et al.. (2016). Abstract P3-07-26: Biomarker comparison between androgen receptor – Positive-triple-negative breast cancer (AR+ TNBC) and quadruple-negative breast cancer (QNBC). Cancer Research. 76(4_Supplement). P3–7. 2 indexed citations
4.
5.
Adams, Sylvia, Sandra Demaria, LJ Goldstein, et al.. (2013). Abstract S1-07: Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. Cancer Research. 73(24_Supplement). S1–7. 13 indexed citations
6.
Karp, JE, Amanda L. Blackford, Kumar Visvanathan, et al.. (2012). Abstract S3-5: Myelodysplatic syndrome and/or acute myelogenous leukemia (MDS and/or AML) after a breast cancer diagnosis: the National Comprehensive Cancer Network (NCCN) experience.. Cancer Research. 72(24_Supplement). S3–5. 6 indexed citations
7.
Goldstein, LJ, Bernhard Heinrich, Salomon M. Stemmer, et al.. (2012). Abstract P5-20-01: A randomized double-blind phase II study of the combination of oral WX-671 plus capecitabine vs. capecitabine monotherapy in first-line HER2− negative metastatic breast cancer (MBC).. Cancer Research. 72(24_Supplement). P5–20. 4 indexed citations
8.
Freedman, Gary M., Barbara Fowble, Karthik Devarajan, et al.. (2011). Risk of Positive Non-sentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status. International Journal of Radiation Oncology*Biology*Physics. 81(2). S207–S207. 4 indexed citations
9.
10.
Gray, Robert P., LJ Goldstein, BH Childs, et al.. (2009). GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer.. Cancer Research. 69(2_Supplement). 25–25. 3 indexed citations
11.
Finn, RS, Carmelo Bengala, Justin Fairchild, et al.. (2009). Phase II trial of dasatinib in triple-negative breast cancer: results of study CA180059.. Cancer Research. 69(2_Supplement). 3118–3118. 59 indexed citations
12.
Leff, A. R. & LJ Goldstein. (2003). Survey methods in stroke medicine. 3(2). 77–84. 1 indexed citations
13.
Fowble, Barbara, Gerald S. Freedman, N. Nicolaou, et al.. (1999). 24 Internal mammary node irradiation does not decrease distant metastases or improve survival in stages I and II breast cancer. International Journal of Radiation Oncology*Biology*Physics. 45(3). 158–159. 1 indexed citations
14.
Goldstein, LJ. (1995). Clinical reversal of drug resistance. Current Problems in Cancer. 19(2). 70–123. 52 indexed citations
15.
Crilley, Pamela & LJ Goldstein. (1995). Peripheral blood stem cell transplant in breast cancer.. PubMed. 22(3). 238–49. 5 indexed citations
16.
Lerman, Caryn, Mary B. Daly, Colleen Burke Sands, et al.. (1993). Mammography Adherence and Psychological Distress Among Women at Risk for Breast Cancer. JNCI Journal of the National Cancer Institute. 85(13). 1074–1080. 361 indexed citations
17.
18.
19.
Goldstein, LJ. (1968). When violin scars jaw, try custom chin rest.. PubMed. 44(9). 48–9. 3 indexed citations
20.
Goldstein, LJ, et al.. (1967). Meniere's disease: twenty years later.. PubMed. 46(6). 746–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Engstrom Breakdown of academic impact, for papers by Susan Tinley Breakdown of academic impact, for papers by Philippe Vennin Breakdown of academic impact, for papers by Marian B. E. Menke‐Pluijmers Breakdown of academic impact, for papers by John Malick Breakdown of academic impact, for papers by Nancy Feldman Breakdown of academic impact, for papers by Brita Arver Breakdown of academic impact, for papers by Carolyn Durham Breakdown of academic impact, for papers by Jocelyne Chiquette Breakdown of academic impact, for papers by R Davidson
Rankless by CCL
2026